Global Metabotropic Glutamate Receptor 5 Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Metabotropic Glutamate Receptor 5 Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Metabotropic Glutamate Receptor 5 by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Metabotropic Glutamate Receptor 5 by Country/Region, 2017, 2022 & 2028

2.2 Metabotropic Glutamate Receptor 5 Segment by Type

2.2.1 Alloswitch-1

2.2.2 BMS-952048

2.2.3 BMS-955829

2.2.4 Dipraglurant ER

2.2.5 Others

2.3 Metabotropic Glutamate Receptor 5 Sales by Type

2.3.1 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2022)

2.3.2 Global Metabotropic Glutamate Receptor 5 Revenue and Market Share by Type (2017-2022)

2.3.3 Global Metabotropic Glutamate Receptor 5 Sale Price by Type (2017-2022)

2.4 Metabotropic Glutamate Receptor 5 Segment by Application

2.4.1 Major Depressive Disorder

2.4.2 Alcohol Addiction

2.4.3 Alzheimer's Disease

2.4.4 Others

2.5 Metabotropic Glutamate Receptor 5 Sales by Application

2.5.1 Global Metabotropic Glutamate Receptor 5 Sale Market Share by Application (2017-2022)

2.5.2 Global Metabotropic Glutamate Receptor 5 Revenue and Market Share by Application (2017-2022)

2.5.3 Global Metabotropic Glutamate Receptor 5 Sale Price by Application (2017-2022)

3 Global Metabotropic Glutamate Receptor 5 by Company

3.1 Global Metabotropic Glutamate Receptor 5 Breakdown Data by Company

3.1.1 Global Metabotropic Glutamate Receptor 5 Annual Sales by Company (2020-2022)

3.1.2 Global Metabotropic Glutamate Receptor 5 Sales Market Share by Company (2020-2022)

3.2 Global Metabotropic Glutamate Receptor 5 Annual Revenue by Company (2020-2022)

3.2.1 Global Metabotropic Glutamate Receptor 5 Revenue by Company (2020-2022)

3.2.2 Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Company (2020-2022)

3.3 Global Metabotropic Glutamate Receptor 5 Sale Price by Company

3.4 Key Manufacturers Metabotropic Glutamate Receptor 5 Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Metabotropic Glutamate Receptor 5 Product Location Distribution

3.4.2 Players Metabotropic Glutamate Receptor 5 Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Metabotropic Glutamate Receptor 5 by Geographic Region

4.1 World Historic Metabotropic Glutamate Receptor 5 Market Size by Geographic Region (2017-2022)

4.1.1 Global Metabotropic Glutamate Receptor 5 Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Metabotropic Glutamate Receptor 5 Annual Revenue by Geographic Region

4.2 World Historic Metabotropic Glutamate Receptor 5 Market Size by Country/Region (2017-2022)

4.2.1 Global Metabotropic Glutamate Receptor 5 Annual Sales by Country/Region (2017-2022)

4.2.2 Global Metabotropic Glutamate Receptor 5 Annual Revenue by Country/Region

4.3 Americas Metabotropic Glutamate Receptor 5 Sales Growth

4.4 APAC Metabotropic Glutamate Receptor 5 Sales Growth

4.5 Europe Metabotropic Glutamate Receptor 5 Sales Growth

4.6 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Growth

5 Americas

5.1 Americas Metabotropic Glutamate Receptor 5 Sales by Country

5.1.1 Americas Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022)

5.1.2 Americas Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022)

5.2 Americas Metabotropic Glutamate Receptor 5 Sales by Type

5.3 Americas Metabotropic Glutamate Receptor 5 Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Metabotropic Glutamate Receptor 5 Sales by Region

6.1.1 APAC Metabotropic Glutamate Receptor 5 Sales by Region (2017-2022)

6.1.2 APAC Metabotropic Glutamate Receptor 5 Revenue by Region (2017-2022)

6.2 APAC Metabotropic Glutamate Receptor 5 Sales by Type

6.3 APAC Metabotropic Glutamate Receptor 5 Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Metabotropic Glutamate Receptor 5 by Country

7.1.1 Europe Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022)

7.1.2 Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022)

7.2 Europe Metabotropic Glutamate Receptor 5 Sales by Type

7.3 Europe Metabotropic Glutamate Receptor 5 Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Metabotropic Glutamate Receptor 5 by Country

8.1.1 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022)

8.1.2 Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022)

8.2 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Type

8.3 Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor 5

10.3 Manufacturing Process Analysis of Metabotropic Glutamate Receptor 5

10.4 Industry Chain Structure of Metabotropic Glutamate Receptor 5

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Metabotropic Glutamate Receptor 5 Distributors

11.3 Metabotropic Glutamate Receptor 5 Customer

12 World Forecast Review for Metabotropic Glutamate Receptor 5 by Geographic Region

12.1 Global Metabotropic Glutamate Receptor 5 Market Size Forecast by Region

12.1.1 Global Metabotropic Glutamate Receptor 5 Forecast by Region (2023-2028)

12.1.2 Global Metabotropic Glutamate Receptor 5 Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Metabotropic Glutamate Receptor 5 Forecast by Type

12.7 Global Metabotropic Glutamate Receptor 5 Forecast by Application

13 Key Players Analysis

13.1 Addex Therapeutics Ltd

13.1.1 Addex Therapeutics Ltd Company Information

13.1.2 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Offered

13.1.3 Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Addex Therapeutics Ltd Main Business Overview

13.1.5 Addex Therapeutics Ltd Latest Developments

13.2 Aevi Genomic Medicine Inc

13.2.1 Aevi Genomic Medicine Inc Company Information

13.2.2 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product Offered

13.2.3 Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Aevi Genomic Medicine Inc Main Business Overview

13.2.5 Aevi Genomic Medicine Inc Latest Developments

13.3 Bristol-Myers Squibb Company

13.3.1 Bristol-Myers Squibb Company Company Information

13.3.2 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product Offered

13.3.3 Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Bristol-Myers Squibb Company Main Business Overview

13.3.5 Bristol-Myers Squibb Company Latest Developments

13.4 Eisai Co Ltd

13.4.1 Eisai Co Ltd Company Information

13.4.2 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product Offered

13.4.3 Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Eisai Co Ltd Main Business Overview

13.4.5 Eisai Co Ltd Latest Developments

13.5 Eli Lilly and Company

13.5.1 Eli Lilly and Company Company Information

13.5.2 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product Offered

13.5.3 Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Eli Lilly and Company Main Business Overview

13.5.5 Eli Lilly and Company Latest Developments

13.6 Heptares Therapeutics Ltd

13.6.1 Heptares Therapeutics Ltd Company Information

13.6.2 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Offered

13.6.3 Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Heptares Therapeutics Ltd Main Business Overview

13.6.5 Heptares Therapeutics Ltd Latest Developments

13.7 Johnson & Johnson

13.7.1 Johnson & Johnson Company Information

13.7.2 Johnson & Johnson Metabotropic Glutamate Receptor 5 Product Offered

13.7.3 Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Johnson & Johnson Main Business Overview

13.7.5 Johnson & Johnson Latest Developments

13.8 Merz Pharma GmbH & Co KgaA

13.8.1 Merz Pharma GmbH & Co KgaA Company Information

13.8.2 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product Offered

13.8.3 Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Merz Pharma GmbH & Co KgaA Main Business Overview

13.8.5 Merz Pharma GmbH & Co KgaA Latest Developments

13.9 Novartis AG

13.9.1 Novartis AG Company Information

13.9.2 Novartis AG Metabotropic Glutamate Receptor 5 Product Offered

13.9.3 Novartis AG Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Novartis AG Main Business Overview

13.9.5 Novartis AG Latest Developments

13.10 Richter Gedeon Nyrt

13.10.1 Richter Gedeon Nyrt Company Information

13.10.2 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product Offered

13.10.3 Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Richter Gedeon Nyrt Main Business Overview

13.10.5 Richter Gedeon Nyrt Latest Developments

13.11 Sumitomo Dainippon Pharma Co Ltd

13.11.1 Sumitomo Dainippon Pharma Co Ltd Company Information

13.11.2 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product Offered

13.11.3 Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Sumitomo Dainippon Pharma Co Ltd Main Business Overview

13.11.5 Sumitomo Dainippon Pharma Co Ltd Latest Developments

13.12 Toray Industries Inc

13.12.1 Toray Industries Inc Company Information

13.12.2 Toray Industries Inc Metabotropic Glutamate Receptor 5 Product Offered

13.12.3 Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Toray Industries Inc Main Business Overview

13.12.5 Toray Industries Inc Latest Developments

14 Research Findings and Conclusion

Table 1. Metabotropic Glutamate Receptor 5 Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Metabotropic Glutamate Receptor 5 Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Alloswitch-1

Table 4. Major Players of BMS-952048

Table 5. Major Players of BMS-955829

Table 6. Major Players of Dipraglurant ER

Table 7. Major Players of Others

Table 8. Global Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)

Table 9. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2022)

Table 10. Global Metabotropic Glutamate Receptor 5 Revenue by Type (2017-2022) & ($ million)

Table 11. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2017-2022)

Table 12. Global Metabotropic Glutamate Receptor 5 Sale Price by Type (2017-2022) & (USD/Pcs)

Table 13. Global Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)

Table 14. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2022)

Table 15. Global Metabotropic Glutamate Receptor 5 Revenue by Application (2017-2022)

Table 16. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application (2017-2022)

Table 17. Global Metabotropic Glutamate Receptor 5 Sale Price by Application (2017-2022) & (USD/Pcs)

Table 18. Global Metabotropic Glutamate Receptor 5 Sales by Company (2020-2022) & (K Pcs)

Table 19. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Company (2020-2022)

Table 20. Global Metabotropic Glutamate Receptor 5 Revenue by Company (2020-2022) ($ Millions)

Table 21. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Company (2020-2022)

Table 22. Global Metabotropic Glutamate Receptor 5 Sale Price by Company (2020-2022) & (USD/Pcs)

Table 23. Key Manufacturers Metabotropic Glutamate Receptor 5 Producing Area Distribution and Sales Area

Table 24. Players Metabotropic Glutamate Receptor 5 Products Offered

Table 25. Metabotropic Glutamate Receptor 5 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global Metabotropic Glutamate Receptor 5 Sales by Geographic Region (2017-2022) & (K Pcs)

Table 29. Global Metabotropic Glutamate Receptor 5 Sales Market Share Geographic Region (2017-2022)

Table 30. Global Metabotropic Glutamate Receptor 5 Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global Metabotropic Glutamate Receptor 5 Sales by Country/Region (2017-2022) & (K Pcs)

Table 33. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Country/Region (2017-2022)

Table 34. Global Metabotropic Glutamate Receptor 5 Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022) & (K Pcs)

Table 37. Americas Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2017-2022)

Table 38. Americas Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2017-2022)

Table 40. Americas Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)

Table 41. Americas Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2022)

Table 42. Americas Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)

Table 43. Americas Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2022)

Table 44. APAC Metabotropic Glutamate Receptor 5 Sales by Region (2017-2022) & (K Pcs)

Table 45. APAC Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2017-2022)

Table 46. APAC Metabotropic Glutamate Receptor 5 Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC Metabotropic Glutamate Receptor 5 Revenue Market Share by Region (2017-2022)

Table 48. APAC Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)

Table 49. APAC Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2022)

Table 50. APAC Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)

Table 51. APAC Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2022)

Table 52. Europe Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022) & (K Pcs)

Table 53. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2017-2022)

Table 54. Europe Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2017-2022)

Table 56. Europe Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)

Table 57. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2022)

Table 58. Europe Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)

Table 59. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Country (2017-2022) & (K Pcs)

Table 61. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Type (2017-2022) & (K Pcs)

Table 65. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales by Application (2017-2022) & (K Pcs)

Table 67. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of Metabotropic Glutamate Receptor 5

Table 69. Key Market Challenges & Risks of Metabotropic Glutamate Receptor 5

Table 70. Key Industry Trends of Metabotropic Glutamate Receptor 5

Table 71. Metabotropic Glutamate Receptor 5 Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. Metabotropic Glutamate Receptor 5 Distributors List

Table 74. Metabotropic Glutamate Receptor 5 Customer List

Table 75. Global Metabotropic Glutamate Receptor 5 Sales Forecast by Region (2023-2028) & (K Pcs)

Table 76. Global Metabotropic Glutamate Receptor 5 Sales Market Forecast by Region

Table 77. Global Metabotropic Glutamate Receptor 5 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global Metabotropic Glutamate Receptor 5 Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 80. Americas Metabotropic Glutamate Receptor 5 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC Metabotropic Glutamate Receptor 5 Sales Forecast by Region (2023-2028) & (K Pcs)

Table 82. APAC Metabotropic Glutamate Receptor 5 Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 84. Europe Metabotropic Glutamate Receptor 5 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Forecast by Country (2023-2028) & (K Pcs)

Table 86. Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global Metabotropic Glutamate Receptor 5 Sales Forecast by Type (2023-2028) & (K Pcs)

Table 88. Global Metabotropic Glutamate Receptor 5 Sales Market Share Forecast by Type (2023-2028)

Table 89. Global Metabotropic Glutamate Receptor 5 Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global Metabotropic Glutamate Receptor 5 Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global Metabotropic Glutamate Receptor 5 Sales Forecast by Application (2023-2028) & (K Pcs)

Table 92. Global Metabotropic Glutamate Receptor 5 Sales Market Share Forecast by Application (2023-2028)

Table 93. Global Metabotropic Glutamate Receptor 5 Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global Metabotropic Glutamate Receptor 5 Revenue Market Share Forecast by Application (2023-2028)

Table 95. Addex Therapeutics Ltd Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors

Table 96. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Offered

Table 97. Addex Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 98. Addex Therapeutics Ltd Main Business

Table 99. Addex Therapeutics Ltd Latest Developments

Table 100. Aevi Genomic Medicine Inc Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors

Table 101. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Product Offered

Table 102. Aevi Genomic Medicine Inc Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 103. Aevi Genomic Medicine Inc Main Business

Table 104. Aevi Genomic Medicine Inc Latest Developments

Table 105. Bristol-Myers Squibb Company Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors

Table 106. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Product Offered

Table 107. Bristol-Myers Squibb Company Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 108. Bristol-Myers Squibb Company Main Business

Table 109. Bristol-Myers Squibb Company Latest Developments

Table 110. Eisai Co Ltd Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors

Table 111. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Product Offered

Table 112. Eisai Co Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 113. Eisai Co Ltd Main Business

Table 114. Eisai Co Ltd Latest Developments

Table 115. Eli Lilly and Company Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors

Table 116. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Product Offered

Table 117. Eli Lilly and Company Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 118. Eli Lilly and Company Main Business

Table 119. Eli Lilly and Company Latest Developments

Table 120. Heptares Therapeutics Ltd Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors

Table 121. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Product Offered

Table 122. Heptares Therapeutics Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 123. Heptares Therapeutics Ltd Main Business

Table 124. Heptares Therapeutics Ltd Latest Developments

Table 125. Johnson & Johnson Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors

Table 126. Johnson & Johnson Metabotropic Glutamate Receptor 5 Product Offered

Table 127. Johnson & Johnson Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 128. Johnson & Johnson Main Business

Table 129. Johnson & Johnson Latest Developments

Table 130. Merz Pharma GmbH & Co KgaA Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors

Table 131. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Product Offered

Table 132. Merz Pharma GmbH & Co KgaA Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 133. Merz Pharma GmbH & Co KgaA Main Business

Table 134. Merz Pharma GmbH & Co KgaA Latest Developments

Table 135. Novartis AG Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors

Table 136. Novartis AG Metabotropic Glutamate Receptor 5 Product Offered

Table 137. Novartis AG Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 138. Novartis AG Main Business

Table 139. Novartis AG Latest Developments

Table 140. Richter Gedeon Nyrt Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors

Table 141. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Product Offered

Table 142. Richter Gedeon Nyrt Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 143. Richter Gedeon Nyrt Main Business

Table 144. Richter Gedeon Nyrt Latest Developments

Table 145. Sumitomo Dainippon Pharma Co Ltd Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors

Table 146. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Product Offered

Table 147. Sumitomo Dainippon Pharma Co Ltd Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 148. Sumitomo Dainippon Pharma Co Ltd Main Business

Table 149. Sumitomo Dainippon Pharma Co Ltd Latest Developments

Table 150. Toray Industries Inc Basic Information, Metabotropic Glutamate Receptor 5 Manufacturing Base, Sales Area and Its Competitors

Table 151. Toray Industries Inc Metabotropic Glutamate Receptor 5 Product Offered

Table 152. Toray Industries Inc Metabotropic Glutamate Receptor 5 Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 153. Toray Industries Inc Main Business

Table 154. Toray Industries Inc Latest Developments

List of Figures

Figure 1. Picture of Metabotropic Glutamate Receptor 5

Figure 2. Metabotropic Glutamate Receptor 5 Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Metabotropic Glutamate Receptor 5 Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Metabotropic Glutamate Receptor 5 Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Metabotropic Glutamate Receptor 5 Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Alloswitch-1

Figure 10. Product Picture of BMS-952048

Figure 11. Product Picture of BMS-955829

Figure 12. Product Picture of Dipraglurant ER

Figure 13. Product Picture of Others

Figure 14. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Type in 2021

Figure 15. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Type (2017-2022)

Figure 16. Metabotropic Glutamate Receptor 5 Consumed in Major Depressive Disorder

Figure 17. Global Metabotropic Glutamate Receptor 5 Market: Major Depressive Disorder (2017-2022) & (K Pcs)

Figure 18. Metabotropic Glutamate Receptor 5 Consumed in Alcohol Addiction

Figure 19. Global Metabotropic Glutamate Receptor 5 Market: Alcohol Addiction (2017-2022) & (K Pcs)

Figure 20. Metabotropic Glutamate Receptor 5 Consumed in Alzheimer's Disease

Figure 21. Global Metabotropic Glutamate Receptor 5 Market: Alzheimer's Disease (2017-2022) & (K Pcs)

Figure 22. Metabotropic Glutamate Receptor 5 Consumed in Others

Figure 23. Global Metabotropic Glutamate Receptor 5 Market: Others (2017-2022) & (K Pcs)

Figure 24. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Application (2017-2022)

Figure 25. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Application in 2021

Figure 26. Metabotropic Glutamate Receptor 5 Revenue Market by Company in 2021 ($ Million)

Figure 27. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Company in 2021

Figure 28. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Geographic Region (2017-2022)

Figure 29. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Geographic Region in 2021

Figure 30. Global Metabotropic Glutamate Receptor 5 Sales Market Share by Region (2017-2022)

Figure 31. Global Metabotropic Glutamate Receptor 5 Revenue Market Share by Country/Region in 2021

Figure 32. Americas Metabotropic Glutamate Receptor 5 Sales 2017-2022 (K Pcs)

Figure 33. Americas Metabotropic Glutamate Receptor 5 Revenue 2017-2022 ($ Millions)

Figure 34. APAC Metabotropic Glutamate Receptor 5 Sales 2017-2022 (K Pcs)

Figure 35. APAC Metabotropic Glutamate Receptor 5 Revenue 2017-2022 ($ Millions)

Figure 36. Europe Metabotropic Glutamate Receptor 5 Sales 2017-2022 (K Pcs)

Figure 37. Europe Metabotropic Glutamate Receptor 5 Revenue 2017-2022 ($ Millions)

Figure 38. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales 2017-2022 (K Pcs)

Figure 39. Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue 2017-2022 ($ Millions)

Figure 40. Americas Metabotropic Glutamate Receptor 5 Sales Market Share by Country in 2021

Figure 41. Americas Metabotropic Glutamate Receptor 5 Revenue Market Share by Country in 2021

Figure 42. United States Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)

Figure 43. Canada Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)

Figure 44. Mexico Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)

Figure 45. Brazil Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)

Figure 46. APAC Metabotropic Glutamate Receptor 5 Sales Market Share by Region in 2021

Figure 47. APAC Metabotropic Glutamate Receptor 5 Revenue Market Share by Regions in 2021

Figure 48. China Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)

Figure 49. Japan Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)

Figure 50. South Korea Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)

Figure 51. Southeast Asia Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)

Figure 52. India Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)

Figure 53. Australia Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)

Figure 54. Europe Metabotropic Glutamate Receptor 5 Sales Market Share by Country in 2021

Figure 55. Europe Metabotropic Glutamate Receptor 5 Revenue Market Share by Country in 2021

Figure 56. Germany Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)

Figure 57. France Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)

Figure 58. UK Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)

Figure 59. Italy Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)

Figure 60. Russia Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)

Figure 61. Middle East & Africa Metabotropic Glutamate Receptor 5 Sales Market Share by Country in 2021

Figure 62. Middle East & Africa Metabotropic Glutamate Receptor 5 Revenue Market Share by Country in 2021

Figure 63. Egypt Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)

Figure 64. South Africa Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)

Figure 65. Israel Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)

Figure 66. Turkey Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)

Figure 67. GCC Country Metabotropic Glutamate Receptor 5 Revenue Growth 2017-2022 ($ Millions)

Figure 68. Manufacturing Cost Structure Analysis of Metabotropic Glutamate Receptor 5 in 2021

Figure 69. Manufacturing Process Analysis of Metabotropic Glutamate Receptor 5

Figure 70. Industry Chain Structure of Metabotropic Glutamate Receptor 5

Figure 71. Channels of Distribution

Figure 72. Distributors Profiles